RT.COM: FDA chief requests probe into own agency’s dealings with pharma firm before controversial approval for Alzheimer’s drug
The Screenshot:
What They Say:
Acting FDA head Janet Woodcock has called for an independent probe into potentially inappropriate contacts between FDA staff and a pharma firm, after the agency drew controversy for approving the company’s dementia drug.